APA (7th ed.) Citation

Bragina, O. D., Chernov, V. I., Garbukov, E. Y., Doroshenko, A. V., Vorobyeva, A. G., Orlova, A. M., & Tolmachev, V. M. (2021). Possibilities of radionuclide diagnostics of Her2-positive breast cancer using technetium-99m-labeled target molecules: The first experience of clinical use. Siberian State Medical University (Tomsk).

Chicago Style (17th ed.) Citation

Bragina, O. D., V. I. Chernov, E. Yu Garbukov, A. V. Doroshenko, A. G. Vorobyeva, A. M. Orlova, and V. M. Tolmachev. Possibilities of Radionuclide Diagnostics of Her2-positive Breast Cancer Using Technetium-99m-labeled Target Molecules: The First Experience of Clinical Use. Siberian State Medical University (Tomsk), 2021.

MLA (9th ed.) Citation

Bragina, O. D., et al. Possibilities of Radionuclide Diagnostics of Her2-positive Breast Cancer Using Technetium-99m-labeled Target Molecules: The First Experience of Clinical Use. Siberian State Medical University (Tomsk), 2021.